Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Safety Issues: early-phase trial registry

2 of 14 indexed Safety Issues trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,230 of 28,707 conditions by registered trial count.

14 US clinical trials · 2 currently recruiting · #1,230 of 28,707 conditions by registered trial count

Safety Issues: 14 US clinical trials tracked, 2 recruiting.

Safety Issues is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is International Partnership for Microbicides, running 1 of these trials.

Enrollment posture brief

Registry condition safety-issues

OPEN 2 | RECR 14% | LATE 0 | EARLY 8 | RANK #1230 | SPON 1

Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)

Acute Respiratory Failure35.7%Adherence, Medication35.7%Acromegaly28.6%Safety Issues (this)14%Abscess7.1%
Open-enrollment share among volume-matched conditions near Safety Issues

Safety Issues lists 2 open slots (14% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Safety Issues on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Safety Issues is recruiting below its size-band peers.

    2 of 14 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Safety Issues trials is spread across many organizations.

    International Partnership for Microbicides accounts for 1 of 14 trials (7.1%). 14 distinct sponsors appear on at least one study for this condition label.

  3. Most Safety Issues trials plan to enrol fewer than 100 people.

    Median target enrolment is 30 among the 14 trials that report a genuine target (sentinel values excluded). 11 of those (78.6%) plan for fewer than 100 participants.

  4. Safety Issues research is mostly interventional.

    13 interventional and 1 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 18

Open and recent trials

14 total, page 1 of 1

RECRUITING NA 400 participants

BeSMART Secure Storage Counseling in the Inpatient Setting

Vanderbilt University Medical Center

NCT06485141

RECRUITING Phase 1 196 participants

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co.

NCT05142592

ACTIVE NOT RECRUITING Phase 1 32 participants

Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis

Georgetown University

NCT05551858

ACTIVE NOT RECRUITING NA 28 participants

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

University of California, San Diego

NCT04002440

ACTIVE NOT RECRUITING Phase 1 13 participants

A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults

IC-MedTech Corporation

NCT05523596

COMPLETED 674 participants

Survey of Housestaff Attitudes Toward Patient Care and Safety

Weill Medical College of Cornell University

NCT00845052

COMPLETED NA 56 participants

Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults

University of South Carolina

NCT05212402

COMPLETED Phase 1 40 participants

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

International Partnership for Microbicides

NCT05041699

COMPLETED NA 30 participants

Buck Institute Ketone Ester RCT

Buck Institute for Research on Aging

NCT05585762

COMPLETED Phase 1 24 participants

A Phase 1 Study of EXT608 in Healthy Adults

Extend Biosciences

NCT05408663

COMPLETED Phase 1 21 participants

Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study

Eastern Virginia Medical School

NCT06274398

COMPLETED Phase 1 21 participants

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

Paion UK

NCT04113343

COMPLETED Phase 1 20 participants

Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression

University of California, San Francisco

NCT04301895

COMPLETED NA 1 participants

Effect of Naringenin and Beta Carotene on Energy Expenditure

Pennington Biomedical Research Center

NCT04697355

Phase Distribution

PhaseTrial count
Phase 1 8

Named interventions

Most-linked intervention names on Safety Issues records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
2 trials
Non-ketone placebo Other
1 trials
IPM Ring-106 Combination
1 trials
IPM Ring-105 Combination
1 trials
Remifentanil infusion Drug
1 trials
Continuous conversational interaction Behavioral
1 trials
Matching placebo rectal insert Drug
1 trials
TAF/EVG rectal insert Drug
1 trials

US sites by state

Facility locations filed on Safety Issues trials. A trial with sites in several states counts in each.

California 3 trials
Texas 2 trials
Oregon 2 trials
Virginia 1 trials
Utah 1 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Safety Issues page

14 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Safety Issues condition card totals 14 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.